Every Form 4 that Red Violet Inc (RDVT) has filed with the SEC in the last 12 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A Form 4 covers the transactions officers, directors and large holders report, so if you follow RDVT and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full RDVT filings page.
Red Violet, Inc. (RDVT) director William Paul Livek reported buying 2,000 shares of the company’s common stock on August 27, 2026 in an open-market or private transaction at $71.49 per share. After this purchase, his directly held position, including various restricted stock units, totals 22,733 shares of common stock or equivalent.
Red Violet, Inc. director Greg Strakosch received an equity award that increases his direct holdings. On June 4, 2026, he was granted 2,088 restricted stock units (RSUs), which convert into common stock on a one-for-one basis at vesting and were reported as common stock with no purchase price.
The new RSUs vest on the earlier of one year from the grant date or the 2027 annual meeting of stockholders, with potential accelerated vesting under certain conditions. Following this award, Strakosch directly holds 7,955 shares of common stock, reflecting a routine, compensation-related increase in his stake.
Red Violet, Inc. director William Paul Livek received an equity grant of 2,088 restricted stock units (RSUs) on June 4, 2026. These RSUs convert into common stock on a one-for-one basis and vest on the earlier of one year from grant or the 2027 annual stockholder meeting, with potential accelerated vesting in certain cases.
After this grant, Livek holds 20,733 shares and RSUs in total, including several prior RSU awards with scheduled vesting dates through December 1, 2028 and 4,517 vested RSUs for which share delivery has been deferred until separation from service, death, or disability.
Red Violet, Inc. director Steven D. Rubin reported a stock-based compensation grant. On June 4, 2026, he received 2,179 restricted stock units (RSUs) that convert into common stock on a one-for-one basis and vest on the earlier of one year from grant or the 2027 annual stockholders’ meeting, subject to possible accelerated vesting.
After this award, Rubin directly holds 147,767 shares of common stock, including several prior RSU grants with vesting dates in 2026–2028 and 59,200 vested RSUs for which he has deferred share delivery until separation from the company, death, or disability.
Stanton Lisa M. reported acquisition or exercise transactions in this Form 4 filing.
Red Violet, Inc. director Lisa M. Stanton received an equity award on June 4, 2026. She was granted 2,179 restricted stock units (RSUs), each convertible into one share of common stock, vesting on the earlier of one year from grant or the 2027 annual meeting of stockholders, with potential accelerated vesting under certain conditions.
Following this grant, Stanton directly holds 33,444 shares and RSUs in total, including prior RSU awards with vesting dates in 2026, 2027, and 2028. This is a compensation-related grant, not an open-market share purchase or sale.
Red Violet, Inc.'s Chief Information Officer, Jeffrey Alan Dell, sold 10,000 shares of common stock in two open-market transactions on June 1, 2026. The sales covered 5,000 shares at $57.25 and 5,000 shares at $57.62 per share, based on weighted average prices within disclosed ranges.
Following these transactions, he directly holds 155,889 shares of common stock. His position includes 10,000 RSUs granted November 30, 2023, 15,750 RSUs granted November 4, 2024, and 13,890 RSUs granted December 19, 2025, which vest in stages from December 2026 through December 2028.
Red Violet, Inc. director and CEO Derek Dubner reported selling 12,000 shares of common stock in open‑market transactions. The sales occurred on June 1, 2026 at prices of $57.24 and $57.62 per share, according to the Form 4.
After these sales, Dubner directly holds 557,273 shares of Red Violet common stock. He also holds unvested restricted stock units, including 13,333 RSUs granted November 30, 2023 that vest on December 1, 2026, 21,000 RSUs granted November 4, 2024 vesting in 2026 and 2027, and 18,520 RSUs granted December 19, 2025 vesting between 2026 and 2028, each convertible one-for-one into common shares.
Red Violet, Inc. Chief Financial Officer Daniel MacLachlan reported open-market sales of a total of 12,000 shares of common stock on June 1, 2026, executed in two 6,000-share blocks. One block had a weighted average price of $57.62 per share and the other $57.24, each across multiple trades within disclosed price ranges.
After these transactions, MacLachlan holds 358,902 shares directly and 466 shares indirectly through an IRA. His position also includes time-vested restricted stock units of 13,333, 21,000, and 18,520 shares scheduled to vest between December 2026 and December 2028, subject to accelerated vesting in certain circumstances.
Red Violet, Inc. President James Patrick Reilly reported open-market sales of a total of 12,000 shares of common stock on June 1, 2026, executed in two 6,000-share transactions. The shares were sold at prices within disclosed ranges, with weighted average prices of $57.62 and $57.24 per share.
Following these sales, Reilly directly owns 232,351 shares of Red Violet common stock. His reported holdings also include unvested restricted stock units: 13,333 RSUs granted November 30, 2023 that vest on December 1, 2026, 21,000 RSUs granted November 4, 2024 that vest in two equal installments on November 1, 2026 and November 1, 2027, and 18,520 RSUs granted December 19, 2025 that vest in three equal installments on December 1, 2026, December 1, 2027, and December 1, 2028, in each case subject to accelerated vesting under certain circumstances.
Red Violet, Inc. director Greg Strakosch reported an equity compensation grant in the form of restricted stock units. On March 2, 2026, he acquired 1,857 RSUs convertible into common stock on a one-for-one basis, awarded in connection with his appointment to the Company’s Audit Committee.
The grant vests over three years: 507 shares on December 1, 2026 and 675 shares on each of December 1, 2027 and December 1, 2028, with potential accelerated vesting under certain conditions. After this grant, his directly held common stock and RSUs total 5,867 shares, including RSUs originally granted in March 2025 and December 2025.
Red Violet, Inc. (RDVT) reported insider activity: Chief Information Officer Jeffrey Dell sold a total of 10,000 shares of common stock across multiple trades from 11/10/2025 to 11/13/2025. The sales were executed in multiple transactions with weighted average prices ranging from $56.72 to $58.81, as detailed in footnotes.
Following these transactions, Dell beneficially owns 155,934 shares directly. This figure includes 20,000 RSUs granted on 11/30/2023 that vest in two equal installments on 12/1/2025 and 12/1/2026, and 15,750 RSUs granted on 11/4/2024 that vest in two equal installments on 11/1/2026 and 11/1/2027. The filing notes that each day’s sales were comprised of multiple trades within disclosed price ranges.
Red Violet (RDVT) reported insider activity by CEO and Chairman Derek Dubner. Between 11/10/2025 and 11/13/2025, he sold a total of 15,000 shares of common stock in seven open‑market transactions. Weighted average prices per tranche ranged from $56.73 to $58.81, with disclosed trade price ranges spanning $56.40 to $58.92.
Following these sales, his beneficial ownership was 556,000 shares, held directly. This figure includes 26,666 RSUs granted on November 30, 2023, scheduled to vest in equal parts on December 1, 2025 and December 1, 2026, and 21,000 RSUs granted on November 4, 2024, scheduled to vest in equal parts on November 1, 2026 and November 1, 2027.
Red Violet, Inc. (RDVT) CFO Daniel MacLachlan reported open‑market sales of common stock on 11/10–11/13/2025, as disclosed in a Form 4. Each day’s trades were executed in multiple transactions, with weighted average prices per share of $58.81 (11/10), $58.03 (11/10), $57.81 (11/11), $58.10 (11/12), $57.80 (11/12), $57.57 (11/13), and $56.73 (11/13). The transactions occurred within an overall price range of $56.40 to $58.92, as noted in the footnotes.
Following these reported sales, the table shows 358,163 shares beneficially owned after an 11/13/2025 transaction. The filing also notes 26,666 RSUs granted on 11/30/2023 vesting in two equal installments on December 1, 2025 and December 1, 2026, and 21,000 RSUs granted on 11/4/2024 vesting in two equal installments on November 1, 2026 and November 1, 2027, each convertible into common stock on a one‑for‑one basis.
Red Violet (RDVT) President James Reilly reported multiple open‑market sales of common stock. Tranches executed from November 10–13, 2025 included 733 shares at a weighted average price of $58.81; 6,273 at $58.03; 2,184 at $57.81; 651 at $58.10; 3,448 at $57.80; 445 at $57.57; and 1,266 at $56.73. Following these transactions, he beneficially owned 231,078 shares directly.
The reported holdings include 26,666 RSUs granted November 30, 2023 (vesting December 1, 2025 and December 1, 2026) and 21,000 RSUs granted November 4, 2024 (vesting November 1, 2026 and November 1, 2027).
Red Violet, Inc. (RDVT) reported an insider transaction on a Form 4. The Chief Information Officer disposed of 7,034 shares of common stock on 11/03/2025 under transaction code F, indicating shares were withheld to satisfy tax obligations, at a price of $53.63.
Following the transaction, the insider beneficially owned 165,934 shares directly. The disposition was tied to the vesting of RSU tranches from awards approved on October 12, 2022 (third tranche of 10,000 RSUs) and November 4, 2024 (first tranche of 7,875 RSUs).
Outstanding RSUs include 20,000 granted on November 30, 2023, vesting in equal installments on December 1, 2025 and December 1, 2026, and 15,750 granted on November 4, 2024, vesting in equal installments on November 1, 2026 and November 1, 2027.
Red Violet, Inc. (RDVT) reported a Form 4 for CEO, Director, and Chairman Derek Dubner. On 11/03/2025, he reported a code F disposition of 9,379 common shares at $53.63 per share to satisfy tax obligations upon RSU vesting. Following the transaction, Dubner reported 571,000 shares beneficially owned, held directly.
Per the footnotes, the tax withholding relates to the vesting of the third tranche of 13,333 RSUs from a grant approved on October 12, 2022 and the first tranche of 10,500 RSUs from a grant approved on November 4, 2024. His holdings include 26,666 RSUs (granted November 30, 2023) vesting in equal parts on December 1, 2025 and December 1, 2026, and 21,000 RSUs (granted November 4, 2024) vesting in equal parts on November 1, 2026 and November 1, 2027, each convertible one-for-one into common stock and subject to accelerated vesting under certain circumstances.
Red Violet, Inc. (RDVT) reported an insider transaction by its Chief Financial Officer. On 11/03/2025, the officer disposed of 9,379 shares of common stock at $53.63 via a Code F transaction, which reflects shares withheld by the issuer to cover taxes upon RSU vesting. Following the transaction, the officer beneficially owns 373,163 shares directly and 466 shares indirectly through an IRA.
The tax withholding relates to vesting tranches from prior RSU grants, including a third tranche of 13,333 RSUs (approved 10/12/2022) and a first tranche of 10,500 RSUs (approved 11/04/2024). Footnotes also note 26,666 RSUs granted 11/30/2023 vesting on 12/01/2025 and 12/01/2026, and 21,000 RSUs granted 11/04/2024 vesting on 11/01/2026 and 11/01/2027.
Red Violet (RDVT) President reported a tax-withholding disposition of 9,379 common shares at $53.63 on 11/03/2025 (Transaction Code F) upon RSU vesting. After this administrative transaction, the insider directly beneficially owns 246,078 shares.
The withholding relates to the vesting of the third tranche of 13,333 RSUs from an October 12, 2022 grant and the first tranche of 10,500 RSUs from a November 4, 2024 grant. Outstanding equity awards include 26,666 RSUs granted November 30, 2023, vesting on December 1, 2025 and December 1, 2026, and 21,000 RSUs granted November 4, 2024, vesting on November 1, 2026 and November 1, 2027.